NCT07629115招募中不适用
A Long-Term Follow-up Study to Evaluate the Safety and Efficacy of the Severe Parkinson's Disease Patients Administered the IPS101A Gene Therapy Product in the IPS101A-10 Phase I Clinical Trial
Innopeutics Corporation1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2026年5月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 6
- 试验地点
- 1
研究概览
简要总结
The purpose of this study is to evaluate the long-term safety of IPS101A and to assess the durability of efficacy in subjects who received IPS101A.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 50 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects who were enrolled in the IPS101A-10 clinical trial and received IPS101A.
- •Subjects and/or their legally acceptable representatives who voluntarily provided written informed consent to participate in this long-term follow-up study after being fully informed of the study, and who agreed to comply with all study-related requirements.
排除标准
- •Subjects who decline to provide consent for participation in the long-term follow-up study, or for whom follow-up assessments are not feasible due to death or other reasons.
- •Subjects who, in the judgment of the investigator, are considered unsuitable for participation in the study due to unwillingness or inability to comply with scheduled study visits or other study-related requirements.
研究组 & 干预措施
The group that received IPS101A
The group of subjects who received IPS101A in the IPS101A-10 clinical trial
研究者
研究点 (1)
Loading locations...
相似试验
招募中
1 期
Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease PatientsParkinson DiseaseParkinson's DiseaseNCT07371338Innopeutics Corporation6
招募中
1 期
A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral SclerosisAmyotrophic Lateral SclerosisNCT07571174Eli Lilly and Company32
招募中
不适用
Long-term safety and efficacy study of riliprubart in participants with CIDP
(LTS)Polyneuropathy, Inflammatory Demyelinating, ChronicjRCT2031250663300
已完成
2 期
LONG-TERM INTERVENTIONAL FOLLOW-UP STUDY UP TO 4 YEARS OF AGE OF CHILDREN WITH PRADER-WILLI SYNDROME INCLUDED IN THE OTBB3 CLINICAL TRIAL AND COMPARISON WITH AN UNTREATED COHORT OF CHILDREN WITH PRADER-WILLI SYNDROME
(OTBB3 FOLLOW-UP)2024-517925-25-00Centre Hospitalier Universitaire De Toulouse65
Enrolling By Invitation
不适用
"Real-world Assessment of BP Control in Patients With Hypertension by the Netrod RDN System" - REACH-RDNHypertensionNCT07273877Shanghai Golden Leaf MedTec Co. Ltd1,000